Profile data is unavailable for this security.
About the company
Tactile Systems Technology, Inc., doing business as Tactile Medical, is a medical technology company that manufactures and distributes medical devices for the treatment of patients with chronic diseases at home. The Company's areas of therapeutic focus are vascular disease, oncology and providing airway clearance therapy for those suffering from chronic respiratory conditions. It is developing and marketing at-home therapies for people suffering from underserved, chronic conditions including lymphedema, lipedema, chronic venous insufficiency and chronic pulmonary disease. It markets Flexitouch Plus and Entre Plus systems as at-home therapies for the treatment of lymphedema and chronic venous insufficiency. It markets AffloVest as an at-home therapy intended to promote airway clearance. Its Flexitouch Plus system is a fully automated, programmable, advanced pneumatic compression device. It also offers Kylee, a free mobile application that helps patients learn about lymphedema.
- Revenue in USD (TTM)311.51m
- Net income in USD18.17m
- Incorporated2006
- Employees1.04k
- LocationTactile Systems Technology Inc3701 Wayzata Blvd, Suite 300MINNEAPOLIS 55416United StatesUSA
- Phone+1 (612) 355-5100
- Fax+1 (612) 355-5101
- Websitehttps://www.tactilemedical.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Neuropace Inc | 94.86m | -23.99m | 479.68m | 209.00 | -- | 26.06 | -- | 5.06 | -0.7535 | -0.7535 | 2.98 | 0.5564 | 0.9321 | 1.46 | 7.16 | 515,565.20 | -23.57 | -35.71 | -28.36 | -44.34 | 76.77 | 73.39 | -25.28 | -60.45 | 3.94 | -3.58 | 0.7603 | -- | 22.14 | 16.67 | 17.64 | -- | -8.15 | -- |
| Mesa Laboratories Inc | 247.54m | 3.73m | 489.33m | 730.00 | 136.88 | 2.62 | 17.02 | 1.98 | 0.6471 | 0.6471 | 44.81 | 33.79 | 0.5678 | 3.40 | 6.28 | 339,097.30 | 0.8564 | -8.81 | 1.13 | -9.71 | 62.40 | 61.98 | 1.51 | -25.15 | 1.45 | 1.62 | 0.4709 | -- | 11.47 | 15.41 | 99.22 | -- | 24.60 | 0.00 |
| Anteris Technologies Global Corp | 2.14m | -84.32m | 520.94m | 136.00 | -- | 55.39 | -- | 243.53 | -2.34 | -2.34 | 0.0594 | 0.1025 | 0.1065 | 1.53 | 11.88 | 15,728.75 | -420.16 | -- | -1,527.00 | -- | 67.94 | -- | -3,945.70 | -- | 0.8032 | -- | 0.046 | -- | -1.16 | -- | -65.77 | -- | -- | -- |
| Orthofix Medical Inc | 818.06m | -119.12m | 525.49m | 1.62k | -- | 1.19 | -- | 0.6424 | -3.04 | -3.04 | 20.82 | 11.20 | 0.9622 | 1.37 | 6.40 | 506,224.00 | -14.01 | -10.81 | -17.28 | -13.34 | 68.27 | 70.31 | -14.56 | -11.57 | 1.38 | -1.35 | 0.2837 | -- | 7.08 | 11.69 | 16.78 | -- | 8.75 | -- |
| Cytek Biosciences Inc | 196.83m | -12.82m | 533.20m | 692.00 | -- | 1.41 | -- | 2.71 | -0.1011 | -0.1011 | 1.54 | 2.96 | 0.3992 | 1.86 | 3.60 | 303,746.90 | -2.60 | 0.3407 | -3.02 | 0.3811 | 53.46 | 58.12 | -6.51 | 0.8678 | 4.48 | -- | 0.0213 | -- | 3.85 | 28.20 | 50.44 | -- | 30.83 | -- |
| Pacific Biosciences of California Inc | 154.58m | -503.63m | 555.51m | 575.00 | -- | 15.39 | -- | 3.59 | -1.69 | -1.69 | 0.5236 | 0.1196 | 0.1372 | 1.80 | 5.15 | 268,841.80 | -44.70 | -16.31 | -47.29 | -17.71 | 30.95 | 34.48 | -325.80 | -156.40 | 5.40 | -19.94 | 0.947 | -- | -23.19 | 11.12 | -1.02 | -- | 16.89 | -- |
| Varex Imaging Corp | 854.40m | -67.70m | 560.62m | 2.40k | -- | 1.18 | -- | 0.6562 | -1.63 | -1.63 | 19.34 | 11.38 | 0.7032 | 1.85 | 6.00 | 356,000.00 | -5.55 | -0.3327 | -6.45 | -0.3955 | 34.15 | 33.16 | -7.89 | -0.4661 | 1.87 | 2.22 | 0.4321 | -- | 4.14 | 2.73 | -47.38 | -- | -0.5159 | -- |
| Tactile Systems Technology Inc | 311.51m | 18.17m | 591.00m | 1.04k | 34.06 | 2.88 | 23.73 | 1.90 | 0.7768 | 0.7768 | 13.28 | 9.18 | 1.14 | 8.38 | 8.07 | 300,398.30 | 6.64 | 1.29 | 7.72 | 1.55 | 49.87 | 49.12 | 5.83 | 1.26 | 3.20 | -- | 0.00 | 0.00 | 6.76 | 9.11 | -40.52 | 9.10 | -15.97 | -- |
| Embecta Corp | 1.08bn | 139.50m | 592.20m | 1.85k | 4.23 | -- | 3.27 | 0.5485 | 2.37 | 2.37 | 18.31 | -10.35 | 0.9757 | 2.27 | 6.35 | 583,621.60 | 12.61 | 16.69 | 16.60 | 22.65 | 63.17 | 66.74 | 12.92 | 15.71 | 1.87 | 3.18 | 1.79 | 13.07 | -3.80 | -0.1033 | 21.84 | -25.93 | -26.03 | -- |
| Beta Bionics Inc | 88.57m | -77.84m | 596.53m | 404.00 | -- | 2.02 | -- | 6.74 | -2.07 | -2.07 | 2.21 | 6.70 | 0.4149 | 2.54 | 8.16 | 304,364.30 | -36.46 | -- | -40.57 | -- | 54.51 | -- | -87.89 | -- | 9.83 | -- | 0.00 | -- | 442.93 | -- | -24.17 | -- | -- | -- |
| Alpha Tau Medical Ltd | 0.00 | -39.97m | 616.46m | 125.00 | -- | 7.95 | -- | -- | -0.5212 | -0.5212 | 0.00 | 0.9099 | 0.00 | -- | -- | 0.00 | -40.90 | -34.28 | -44.43 | -36.47 | -- | -- | -- | -- | -- | -- | 0.0735 | -- | -- | -- | -8.89 | -- | 11.60 | -- |
| SI-Bone Inc | 193.58m | -21.76m | 650.00m | 349.00 | -- | 3.77 | -- | 3.36 | -0.5113 | -0.5113 | 4.55 | 3.98 | 0.8393 | 1.29 | 7.53 | 554,664.80 | -9.43 | -24.17 | -10.61 | -26.87 | 79.62 | 82.72 | -11.24 | -40.93 | 6.62 | -- | 0.1711 | -- | 20.37 | 19.96 | 28.67 | -- | 33.83 | -- |
| Bioventus Inc | 563.83m | 7.82m | 670.38m | 950.00 | 72.11 | 4.04 | 11.69 | 1.19 | 0.1123 | 0.1123 | 8.39 | 2.01 | 0.7666 | 1.95 | 4.47 | 606,267.80 | 1.31 | -6.29 | 1.89 | -8.49 | 67.76 | 67.40 | 1.71 | -12.07 | 1.14 | 1.73 | 0.616 | -- | 11.89 | 11.00 | 65.33 | -- | -15.55 | -- |
| Avanos Medical Inc | 699.90m | -468.60m | 685.14m | 2.23k | -- | 0.8806 | -- | 0.9789 | -10.18 | -10.18 | 15.09 | 16.76 | 0.5139 | 2.14 | 5.76 | 314,279.30 | -34.41 | -4.82 | -39.66 | -5.42 | 52.28 | 54.01 | -66.95 | -11.32 | 1.36 | 8.92 | 0.1167 | -- | 2.15 | -0.2826 | -3,802.02 | -- | -18.86 | -- |
Data as of Feb 12 2026. Currency figures normalised to Tactile Systems Technology Inc's reporting currency: US Dollar USD
57.24%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Morgan Stanley & Co. LLCas of 30 Sep 2025 | 2.12m | 9.48% |
| Cadian Capital Management LPas of 30 Sep 2025 | 2.06m | 9.20% |
| BlackRock Fund Advisorsas of 30 Sep 2025 | 1.62m | 7.27% |
| Paradigm Capital Management, Inc.as of 30 Sep 2025 | 1.54m | 6.89% |
| The Vanguard Group, Inc.as of 31 Dec 2025 | 1.48m | 6.61% |
| Dimensional Fund Advisors LPas of 31 Dec 2025 | 1.10m | 4.90% |
| Capitolis Liquid Global Markets LLCas of 30 Sep 2025 | 902.06k | 4.04% |
| Acadian Asset Management LLCas of 30 Sep 2025 | 845.45k | 3.79% |
| Geode Capital Management LLCas of 30 Sep 2025 | 570.57k | 2.56% |
| DWS Investments (UK) Ltd.as of 30 Sep 2025 | 558.33k | 2.50% |
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
